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e Abstract—We report a case of abdominal pain with
rigidity, mimicking an acute abdomen, caused by metoclo-
pramide, a common anti-emetic drug. Extrapyramidal
symptoms are commonly reported side-effects of this med-
ication. They generally include involuntary movements of
limbs, torticollis, oculogyric crisis, rhythmic protrusion of
tongue, trismus, or dystonic reactions resembling tetanus,
etc. Abdominal rigidity due to this medication, resembling
an acute abdomen, has not been reported previously. This
case report illustrates the importance of considering med-
ication side-effects when evaluating a patient with abdom-
inal pain and rigidity. © 2006 Elsevier Inc.
e Keywords—metoclopramide; abdominal pain; extrapy-
ramidal symptoms; dystonia; adverse drug effect
INTRODUCTION
Abdominal pain is a common presentation to the Emer-
gency Department (ED), accounting for 5–10% of all ED
visits (1). It is not always possible to determine the cause
of acute abdominal pain in the ED. In fact, as many as
30% of patients with abdominal pain are discharged
without a specific diagnosis, making “nonspecific ab-
dominal pain” the most frequent diagnosis assigned to
patients in the ED (2). Although specific diagnosis is not
an exception, physicians are expected to identify, with
high sensitivity, patients with an acute surgical abdomen.
One criterion to clinically diagnose an acute surgical
abdomen is to document abdominal muscle rigidity, a
sign of peritonitis. We present a case report highlighting
drug-induced abdominal muscle rigidity, mimicking an
acute abdomen resulting in a serious consideration for
laparotomy. The actual cause was a very commonly used
medication, metoclopramide (trade name Reglan).
CASE PRESENTATION
A 27-year-old man presented to the ED with a 3-h
history of sudden-onset central abdominal pain. The pain
started at rest and was described as moderate-to-severe in
intensity, stretching in character, and episodic in nature.
There were no exacerbating or relieving factors, includ-
ing no change with movement, position or breathing. The
patient’s last meal was 6 h before presentation to the ED.
The patient was passing flatus and his last bowel move-
ment was 8 h before arrival. He denied any nausea,
vomiting, anorexia, urinary burning, frequency or hema-
turia, and denied any history of trauma.
Three days before this visit he had a high grade fever
with temperature of 40°C (104°F) associated with chills
and rigors. He also had associated nausea and vomiting.
A diagnostic work-up at that time revealed malarial
parasites Plasmodium Vivax on a peripheral smear.
Forty-eight hours before this presentation, the patient
was started on a standard regimen of chloroquin for
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malaria and standard dose of metoclopramide 10 mg
three times a day for nausea and vomiting. Since then,
the patient had remained afebrile and the nausea and
vomiting was controlled. He took his last dose of meto-
clopramide 1 h before the onset of abdominal pain. He
denied any other medical problem. He denied any history
of alcohol or drug abuse.
On examination, the patient was a lean young man in
pain. The initial vital signs were pulse rate of 88 beats/
min, blood pressure 120/90 mm Hg, oral temperature
36.6°C, and respiratory rate 20 breaths/min. Positive
findings on physical examination included blanching er-
ythema of the entire trunk from neck down to the ab-
dominal wall and back and a non-distended tender ab-
domen with board-like rigidity. There was no rebound
tenderness. Bowel sounds were present and normal. The
rest of the examination, including chest and lung exam-
ination, was within normal limits.
An initial impression of acute abdomen secondary to a
perforated viscus was made. The patient received intrave-
nous crystalloid fluid bolus and appropriate laboratory stud-
ies were ordered. Surgical consultation was also obtained
and morphine and metoclopramide were administered in-
travenously for pain control. The patient’s laboratory results
revealed normal hemoglobin, hematocrit and platelet count.
The WBC count was 5300 per mm3 with a differential
count of 47.2% neutrophils, 38.9% lymphocyte, 3.1% eo-
sinophils and 10.7% monocytes. Other laboratory studies
including serum glucose, BUN, creatinine, and electrolytes
were within normal limits. Chest X-ray and supine abdom-
inal X-rays were unremarkable with no evidence of free air
or bowel obstruction. Ultrasound of the abdomen revealed
no abnormality.
While in the ED, the patient started to complain about
the stretching pain in his arm muscles, similar to the pain
he was having in his abdomen. Examination of his upper
extremities revealed increased muscle tone. With a neg-
ative abdominal pain work-up, involvement of upper
extremities and a history of being on metoclopramide, a
presumptive diagnosis of dystonic reaction was made.
The patient was given 5 mg of intravenous Procyclidine
(an antiparkinsonian anticholinergic) with marked im-
provement in his symptoms within minutes, and com-
plete resolution in about 30 min. Repeat physical exam-
ination revealed normal vital signs and a completely soft,
non-tender abdomen. At that point, the patient was dis-
charged home. Follow-up of the patient over 6 months
did not reveal any recurrence of abdominal pain.
DISCUSSION
Metoclopramide has been used as an anti-emetic since
the 1960s and is generally considered safe and effective
(3–5). The anti-emetic properties of metoclopramide are
due to its antagonism of central and peripheral dopamine
receptors, which is also responsible for many of its
adverse effects, including the extrapyramidal symptoms
(EPS) (3–6). The EPS occurs in 0.2% (1 out of 500)
patients and manifests primarily as acute dystonic reac-
tions (3–9). The acute dystonia tends to occur in the first
24–48 h of treatment and is seen more frequently in
children and young adults and those receiving higher
doses used in prophylaxis of vomiting during cancer
chemotherapy (3).
Acute dystonia due to anti-dopaminergic drugs is a
fairly common presentation to the ED and generally
involves face and neck muscles. Although less common
presentations such as laryngospasm have been described
(3), involvement of abdominal muscles has not been
documented in published peer-reviewed literature.
Besides metoclopramide, our patient had been on
chloroquin, which is yet another agent causing EPS, with
an incidence of 1 in 5000 (10–13). Like metoclopramide,
chloroquin-induced dystonia has also been described to
involve only the face, neck or limbs and not the abdom-
inal muscles (10–13). Because the patient’s symptoms
worsened with further doses of metoclopramide in the
ED, we believe it is a more likely cause.
Although acute surgical causes of abdominal pain
should still be high on the differential diagnosis list, the
drug-induced abdominal wall spasms should be consid-
ered if the clinical and diagnostic test picture does not fit
the pattern of acute peritonitis or acute abdomen. Our
patient had normal vital signs, normal WBC count, and
normal imaging studies, which decrease the likelihood of
an infectious/inflammatory process in the abdomen. The
ability to reverse symptoms with drugs like diphenhy-
dramine or benztropine and the potential avoidance of
unnecessary laparotomy are good reasons to review med-
ication history and consider this as a possibility if the
clinical picture does not make complete sense.
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